EXAS logo

Exact Sciences (EXAS) Shareholders equity

annual shareholders equity:

$2.40B-$743.06M(-23.62%)
December 31, 2024

Summary

  • As of today (May 29, 2025), EXAS annual stockholders equity is $2.40 billion, with the most recent change of -$743.06 million (-23.62%) on December 31, 2024.
  • During the last 3 years, EXAS annual shareholders equity has fallen by -$985.39 million (-29.09%).
  • EXAS annual shareholders equity is now -29.09% below its all-time high of $3.39 billion, reached on December 31, 2021.

Performance

EXAS Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASbalance sheet metrics

quarterly shareholders equity:

$2.40B-$5.34M(-0.22%)
March 31, 2025

Summary

  • As of today (May 29, 2025), EXAS quarterly stockholders equity is $2.40 billion, with the most recent change of -$5.34 million (-0.22%) on March 31, 2025.
  • Over the past year, EXAS quarterly shareholders equity has dropped by -$735.71 million (-23.49%).
  • EXAS quarterly shareholders equity is now -34.31% below its all-time high of $3.65 billion, reached on March 31, 2021.

Performance

EXAS quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXASbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

EXAS Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.6%-23.5%
3 y3 years-29.1%-26.4%
5 y5 years+5.0%-5.5%

EXAS Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-29.1%at low-26.4%at low
5 y5-year-29.1%+7.5%-34.3%+7.2%
alltimeall time-29.1%>+9999.0%-34.3%>+9999.0%

EXAS Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$2.40B(-0.2%)
Dec 2024
$2.40B(-23.6%)
$2.40B(-25.2%)
Sep 2024
-
$3.21B(+0.6%)
Jun 2024
-
$3.19B(+1.9%)
Mar 2024
-
$3.13B(-0.4%)
Dec 2023
$3.15B(+3.4%)
$3.15B(+0.8%)
Sep 2023
-
$3.12B(+2.1%)
Jun 2023
-
$3.06B(-0.0%)
Mar 2023
-
$3.06B(+0.5%)
Dec 2022
$3.04B(-10.2%)
$3.04B(-2.1%)
Sep 2022
-
$3.11B(-3.1%)
Jun 2022
-
$3.21B(-1.5%)
Mar 2022
-
$3.26B(-3.8%)
Dec 2021
$3.39B(+51.5%)
$3.39B(-2.0%)
Sep 2021
-
$3.46B(-2.9%)
Jun 2021
-
$3.56B(-2.5%)
Mar 2021
-
$3.65B(+63.2%)
Dec 2020
$2.24B(-2.3%)
$2.24B(-4.3%)
Sep 2020
-
$2.34B(-6.9%)
Jun 2020
-
$2.51B(-1.0%)
Mar 2020
-
$2.54B(+10.9%)
Dec 2019
$2.29B(+236.0%)
$2.29B(+205.8%)
Sep 2019
-
$748.28M(-2.3%)
Jun 2019
-
$765.53M(-1.5%)
Mar 2019
-
$776.94M(+14.1%)
Dec 2018
$680.94M(+30.8%)
$680.94M(-5.0%)
Sep 2018
-
$716.73M(-3.7%)
Jun 2018
-
$744.39M(+8.4%)
Mar 2018
-
$687.02M(+32.0%)
Dec 2017
$520.42M(+55.2%)
$520.42M(-1.3%)
Sep 2017
-
$527.14M(-2.5%)
Jun 2017
-
$540.69M(+74.7%)
Mar 2017
-
$309.52M(-7.7%)
Dec 2016
$335.30M(+2.6%)
$335.30M(-7.5%)
Sep 2016
-
$362.33M(+45.3%)
Jun 2016
-
$249.39M(-13.5%)
Mar 2016
-
$288.33M(-11.8%)
Dec 2015
$326.86M(+13.1%)
$326.86M(-9.5%)
Sep 2015
-
$361.29M(+60.7%)
Jun 2015
-
$224.84M(-12.9%)
Mar 2015
-
$258.21M(-10.6%)
Dec 2014
$288.98M(+113.6%)
$288.98M(+34.3%)
Sep 2014
-
$215.10M(-11.4%)
Jun 2014
-
$242.87M(+99.5%)
Mar 2014
-
$121.76M(-10.0%)
Dec 2013
$135.32M(+37.2%)
$135.32M(-6.7%)
Sep 2013
-
$145.09M(-5.5%)
Jun 2013
-
$153.58M(+72.3%)
Mar 2013
-
$89.13M(-9.6%)
Dec 2012
$98.59M
$98.59M(-10.9%)
DateAnnualQuarterly
Sep 2012
-
$110.66M(+72.8%)
Jun 2012
-
$64.02M(-15.6%)
Mar 2012
-
$75.86M(-9.1%)
Dec 2011
$83.50M(+4.7%)
$83.50M(+29.3%)
Sep 2011
-
$64.59M(-8.9%)
Jun 2011
-
$70.89M(-7.1%)
Mar 2011
-
$76.28M(-4.4%)
Dec 2010
$79.75M(+1208.7%)
$79.75M(+348.0%)
Sep 2010
-
$17.80M(-13.3%)
Jun 2010
-
$20.54M(+333.5%)
Mar 2010
-
$4.74M(-22.3%)
Dec 2009
$6.09M(-350.5%)
$6.09M(-15.9%)
Sep 2009
-
$7.25M(+4.0%)
Jun 2009
-
$6.97M(-709.1%)
Mar 2009
-
-$1.14M(-53.0%)
Dec 2008
-$2.43M(-138.7%)
-$2.43M(+379.9%)
Sep 2008
-
-$507.00K(-122.6%)
Jun 2008
-
$2.24M(-44.5%)
Mar 2008
-
$4.04M(-35.7%)
Dec 2007
$6.29M(-58.0%)
$6.29M(-35.5%)
Sep 2007
-
$9.75M(-22.4%)
Jun 2007
-
$12.55M(-7.5%)
Mar 2007
-
$13.57M(-9.3%)
Dec 2006
$14.96M(-39.2%)
$14.96M(-11.2%)
Sep 2006
-
$16.85M(-11.3%)
Jun 2006
-
$18.99M(-11.8%)
Mar 2006
-
$21.54M(-12.5%)
Dec 2005
$24.62M(-35.2%)
$24.62M(-9.7%)
Sep 2005
-
$27.26M(-10.8%)
Jun 2005
-
$30.55M(-9.5%)
Mar 2005
-
$33.75M(-11.1%)
Dec 2004
$37.98M(+210.6%)
$37.98M(-10.5%)
Sep 2004
-
$42.43M(-8.8%)
Jun 2004
-
$46.50M(-8.0%)
Mar 2004
-
$50.56M(+313.4%)
Dec 2003
$12.23M(-68.1%)
$12.23M(-31.4%)
Sep 2003
-
$17.82M(-24.5%)
Jun 2003
-
$23.59M(-23.9%)
Mar 2003
-
$30.99M(-19.2%)
Dec 2002
$38.35M(-35.0%)
$38.35M(-14.5%)
Sep 2002
-
$44.83M(-12.8%)
Jun 2002
-
$51.44M(-1.5%)
Mar 2002
-
$52.20M(-11.5%)
Dec 2001
$58.97M(+112.9%)
$58.97M(-8.6%)
Sep 2001
-
$64.54M(-6.8%)
Jun 2001
-
$69.26M(-6.5%)
Mar 2001
-
$74.07M
Dec 2000
$27.70M(+528.1%)
-
Dec 1999
$4.41M(-52.6%)
-
Dec 1998
$9.30M
-

FAQ

  • What is Exact Sciences annual stockholders equity?
  • What is the all time high annual shareholders equity for Exact Sciences?
  • What is Exact Sciences annual shareholders equity year-on-year change?
  • What is Exact Sciences quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Exact Sciences?
  • What is Exact Sciences quarterly shareholders equity year-on-year change?

What is Exact Sciences annual stockholders equity?

The current annual shareholders equity of EXAS is $2.40B

What is the all time high annual shareholders equity for Exact Sciences?

Exact Sciences all-time high annual stockholders equity is $3.39B

What is Exact Sciences annual shareholders equity year-on-year change?

Over the past year, EXAS annual stockholders equity has changed by -$743.06M (-23.62%)

What is Exact Sciences quarterly stockholders equity?

The current quarterly shareholders equity of EXAS is $2.40B

What is the all time high quarterly shareholders equity for Exact Sciences?

Exact Sciences all-time high quarterly stockholders equity is $3.65B

What is Exact Sciences quarterly shareholders equity year-on-year change?

Over the past year, EXAS quarterly stockholders equity has changed by -$735.71M (-23.49%)
On this page